Boundless Bio, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
BOLD Nasdaq 2836 boundlessbio.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Boundless Bio, Inc.

Boundless Bio Reports First Quarter 2026 Financial Results and Business Highlights - May 8th, 2026 5:00 am
Boundless Bio Presents Preclinical Breast Cancer Data from its Oral Kinesin Degrader Program at 2026 AACR Annual Meeting - Apr 17th, 2026 2:49 pm
Boundless Bio Announces Upcoming Presentation of Oral Kinesin Degrader Program at the American Association for Cancer Research Annual Meeting 2026 - Mar 17th, 2026 2:52 pm
Boundless Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights - Mar 9th, 2026 5:00 am
Boundless Bio to Participate in the Leerink Global Healthcare Conference - Mar 4th, 2026 5:00 am
Boundless Bio, Inc. (BOLD) Upgraded to Buy: Here's Why - Feb 13th, 2026 10:00 am
Boundless Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 - Feb 5th, 2026 5:00 am
We're Keeping An Eye On Boundless Bio's (NASDAQ:BOLD) Cash Burn Rate - Jan 31st, 2026 7:19 am
Boundless Bio Advances Novel Kinesin Degrader Program BBI-940 and Extends Cash Runway - Jan 20th, 2026 5:00 am
Boundless Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference - Nov 24th, 2025 5:00 am
Boundless Bio Reports Third Quarter 2025 Financial Results and Business Highlights - Nov 5th, 2025 5:00 am
Boundless Bio Announces Upcoming Presentation at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics - Oct 13th, 2025 2:05 pm
Here's Why We're Watching Boundless Bio's (NASDAQ:BOLD) Cash Burn Situation - Aug 24th, 2025 7:43 am
Boundless Bio Reports Second Quarter 2025 Financial Results and Business Highlights - Aug 5th, 2025 5:00 am
Boundless Bio to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference - Jun 5th, 2025 2:58 pm